289 related articles for article (PubMed ID: 24330821)
1. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
Quintanilla RA; Jin YN; von Bernhardi R; Johnson GV
Mol Neurodegener; 2013 Dec; 8():45. PubMed ID: 24330821
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
Choo YS; Johnson GV; MacDonald M; Detloff PJ; Lesort M
Hum Mol Genet; 2004 Jul; 13(14):1407-20. PubMed ID: 15163634
[TBL] [Abstract][Full Text] [Related]
3. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.
Milakovic T; Quintanilla RA; Johnson GV
J Biol Chem; 2006 Nov; 281(46):34785-95. PubMed ID: 16973623
[TBL] [Abstract][Full Text] [Related]
4. Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin.
Okada N; Yako T; Nakamura S; Shimazawa M; Hara H
J Pharmacol Sci; 2021 Dec; 147(4):367-375. PubMed ID: 34663519
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
[TBL] [Abstract][Full Text] [Related]
6. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.
Ruan Q; Lesort M; MacDonald ME; Johnson GV
Hum Mol Genet; 2004 Apr; 13(7):669-81. PubMed ID: 14962977
[TBL] [Abstract][Full Text] [Related]
7. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
8. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
9. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
Ruan Q; Quintanilla RA; Johnson GV
J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.
Siddiqui A; Rivera-Sánchez S; Castro Mdel R; Acevedo-Torres K; Rane A; Torres-Ramos CA; Nicholls DG; Andersen JK; Ayala-Torres S
Free Radic Biol Med; 2012 Oct; 53(7):1478-88. PubMed ID: 22709585
[TBL] [Abstract][Full Text] [Related]
11. Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease.
Quintanilla RA; Tapia C; Pérez MJ
Biochem Biophys Res Commun; 2017 Feb; 483(4):1078-1083. PubMed ID: 27638306
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
13. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
[TBL] [Abstract][Full Text] [Related]
14. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
15. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM
J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.
Sedlic F; Sepac A; Pravdic D; Camara AK; Bienengraeber M; Brzezinska AK; Wakatsuki T; Bosnjak ZJ
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C506-15. PubMed ID: 20519447
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease.
Panov AV; Burke JR; Strittmatter WJ; Greenamyre JT
Arch Biochem Biophys; 2003 Feb; 410(1):1-6. PubMed ID: 12559971
[TBL] [Abstract][Full Text] [Related]
19. hMTH1 expression protects mitochondria from Huntington's disease-like impairment.
Ventura I; Russo MT; De Nuccio C; De Luca G; Degan P; Bernardo A; Visentin S; Minghetti L; Bignami M
Neurobiol Dis; 2013 Jan; 49(12):148-58. PubMed ID: 22974734
[TBL] [Abstract][Full Text] [Related]
20. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
